1. Histamine H2-receptor antagonistic action of N-{3-[3-(1-piperidi- nylmethyl)phenoxy]propyl} acetoxyacetamide hydrochloride (TZU- 0460);Tarutani;Arzneim.-Forsch./Drug Res,1985
2. General pharmacological studies on TZU-0460, a new H2-receptor antagonist;Miyasaka;Jpn. Pharmacol. Ther.,1985
3. Roxatidine acetate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic potential in peptic ulcer disease and related disorders;Murdoch;Drugs,1991
4. Pharmacokinetics of roxatidine in healthy volunteers;Collins;Drugs,1988
5. Metabolic fate of 2-Acetoxy-N-[3-[m-(1-piperidinylmethyl)- phenoxy«propyl] acetamide hydrochloride (TZU-0460), a H2-recep- tor antagonist (3). —Absorption and excretion in dogs—;Akutsu;Jpn. Pharmacol. Ther.,1985